This experiment was conducted in the city of Amara in southern Iraq at Al-Sadr Hospital. The study aimedto evaluate the effect of administering Ascorbic Acid on 50 diabeticpatients who had insulin resistance afterthey were diagnosed clinicallyof 25 patients were treated with Ascorbic acid at dose 500 mg twice a day for12 days and the others 25 were considered as control.The study group demonstrated a significant decrease in the fasting patient’s blood sugar (F.B.S), insulin andfasting blood, and Insulin resistance at the end of 12 weeks (P0.05) as compared to baseline measurements.The reduction in F.B.S, Fasting Insulin, and Insulin resistance was significantly reduced in the ascorbic acidgroup at week 12 of the study relative to the control group (P <0.05).
Copyrights © 2021